Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Name: Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
License: Public Domain

TuHURA Biosciences, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced or metastatic merkel cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 429769
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.